Financials

  • Market Capitalization 89.89 M
  • Employee 6
  • Founded 2004
  • CEO Todd C. Brady M.D., Ph.D.
  • Website www.aldeyra.com
  • Headquarter Delaware, United States
  • FIGI BBG0029H8ZF6
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-5.61
ratio cours/chiffre d'affaires

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
3966
ICCC
ImmuCell Corporation - Common Stock
9.92 USD+1.33%+0.71%-12.44%+52.15%90.10 M USD
3967
VRCA
Verrica Pharmaceuticals Inc. - Common Stock
5.24 USD-4.03%+7.82%+0.38%-12.96%90.02 M USD
3976
FBIO
Fortress Biotech, Inc. - Common Stock
2.68 USD-2.19%-3.94%-7.59%-11.84%89.38 M USD
3980
ACRV
Acrivon Therapeutics, Inc. - Common Stock
2.07 USD-0.96%-4.61%+36.18%+55.64%88.71 M USD

Nouvelles